Mark Neumann has an estimated net worth of $26.5 Million. This is based on reported shares across multiple companies, which include Intra-Cellular Therapies, Inc., and Veradermics, Inc.

2023 was Mark Neumann's most active year for acquiring shares with 7 total transactions. Mark Neumann's most active month to acquire stocks was the month of January. 2023 was Mark Neumann's most active year for disposing of shares, totalling 19 transactions. Mark Neumann's most active month to dispose stocks was the month of January. 2022 saw Mark Neumann paying a total of $1,099,210.04 for 166,291 shares, this is the most they've acquired in one year. In 2025 Mark Neumann cashed out on 192,294 shares for a total of $9,187,063.32, their largest year based on trade value.